<DOC>
	<DOCNO>NCT01791296</DOCNO>
	<brief_summary>Specific Aims 1 . Establish feasibility large trial implement sleep protocol ICU 2 different site . Specifically estimate recruitment rate patient compliance intervention . 2 . Measure safety tolerance add night-time sedation dexmedetomidine use adverse effect withdrawal rate indicator . 3 . Measure effect nocturnal dexmedetomidine pertinent clinical outcome use outcome data plan large , multicenter trial area . The goal study determine whether night-time protocol incorporate pharmacologic intervention associate improved sleep ( i.e . dexmedetomidine ) improve sleep quality reduce incidence delirium sub-syndromal delirium critically ill patient .</brief_summary>
	<brief_title>Does Nightly Dexmedetomidine Improve Sleep Reduce Delirium ICU Patients ?</brief_title>
	<detailed_description>The goal study determine whether nocturnal protocol incorporate pharmacologic intervention associate improved sleep ( i.e . dexmedetomidine ) improve sleep quality reduce incidence delirium sub-syndromal delirium critically ill patient ventilator setting optimize optimize sleep quality . 1 . To evaluate impact dexmedetomidine-focussed nocturnal sleep protocol minimize arousal sleep : 1. incidence delirium [ Intensive Care Delirium Screening Checklist ( ICDSC ) score ≥ 4 ] 2. incidence sub-syndromal delirium ( ICDSC score 1-3 ) 3. outcome specifically define place discharge hospital ( i.e. , home , rehabilitation , long-term care ) 2 . To gain understanding effect night-time sedation dexmedetomidine : 1. patient safety 2. self-reported sleep quality 3. sleep quality architecture [ base subgroup 10 patient Tufts Medical Center evaluate use polysomnography ( PSG ) one night ] 4. time spend within target sedation goal 5. time spend without pain 6. agitation-related event 7. length stay ICU 8. duration mechanical ventilation 9. length hospital stay 10. total health care cost measure medication cost hospitalization cost , well calculate effectiveness ( sleep , sedation pain management vs. cost ) . This multicenter study perform : 1 . Hopital Maissonneuve Rosemont , Montreal , PQ 2 . Tufts Medical Center , Boston , MA</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Sleep Deprivation</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1 . Age ≥ 18 year 2 . Current expectation part patient 's admitting intensivist patient require ICU care &gt; /= 48 hr 3 . Administered least one sedative dose ( schedule prn ) . 1 . Patients delirium ( intensive care delirium screen checklist score ≥ 4 ) disorientation ( orient person and/or place ) 2 . Patients ICDSC reliably complete ( e.g . primary language French English , baseline severe hear impairment ) 3 . Inability one investigator obtain informed consent legally authorize representative 4 . Treating physician refusal 5 . Heart rate ≤ 50 BPM 6 . Systolic blood pressure ≤ 90 mmHg despite administration norepinephrine ≥ 15 mcg/min and/or vasopressin ≥ 0.04 units/min 7 . Admission acute decompensated heart failure 8 . History heart block without pacemaker base hospital admission note . 9 . Acute alcohol withdrawal base hospital admission note 10 . History end stage liver failure ( base presence ≥ 1 following : AST/ALT ≥ 2 time ULN , INR ≥ 2 , total bilirubin ≥ 1.5 ) 11 . Irreversible brain disease consistent severe dementia base hospital admission note 12 . Pregnancy ( woman childbearing age undergo pregnancy test prior study enrolment ) 13 . Known allergy sensitivity clonidine dexmedetomidine 14 . Current treatment dexmedetomidine p. Prognosis consider hopeless base consultation ICU admit physician q . Age ≥80 year r. Currently manage high frequency oscillate mode ( HFOV ) mechanical ventilation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>sedation</keyword>
	<keyword>sleep</keyword>
	<keyword>delirium</keyword>
	<keyword>critical illness</keyword>
	<keyword>sub-syndromal delirium</keyword>
	<keyword>intensive care</keyword>
</DOC>